An update to the American Cancer Society (ACS) guideline regarding screening for the early detection of cervical neoplasia and cancer, based on recommendations from a formal review and recent workshop, is presented. The new screening recommendations address when to begin screening, when screening may be discontinued, whether to screen women who have had a hysterectomy, appropriate screening intervals, and new screening technologies, including liquid-based cytology and HPV DNA testing.
1Breast and Gynecologic Cancer, American Cancer Society, Atlanta, GA; 2Department of Obstetrics and Gynecology, St. Lukes-Roosevelt Hospital Center, New York, NY; 3ASCUS/LSIL Triage Study, National Cancer Institute, Rockville, MD; 4Teen Colposcopy Clinic and Division of Adolescent Medicine, University of California, San Francisco, CA; 5Cancer Screening, American Cancer Society, Atlanta, GA; 6Research and Cancer Control, American Cancer Society, Atlanta, GA, and Editor in Chief of CA; and 7Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Science, The Mount Sinai Medical Center, New York, NY
Reprint requests to: Debbie Saslow, PhD, American Cancer Society, National Home Office, 1599 Clifton Road, Atlanta, GA 30329-4251. E-mail: firstname.lastname@example.org
Originally published in CA Cancer J Clin 2002;52:342–362.